4-86701350-T-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_080683.3(PTPN13):ā€‹c.744T>Gā€‹(p.Asp248Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000908 in 1,612,720 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00086 ( 0 hom., cov: 32)
Exomes š‘“: 0.00091 ( 1 hom. )

Consequence

PTPN13
NM_080683.3 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.0360
Variant links:
Genes affected
PTPN13 (HGNC:9646): (protein tyrosine phosphatase non-receptor type 13) The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP is a large intracellular protein. It has a catalytic PTP domain at its C-terminus and two major structural domains: a region with five PDZ domains and a FERM domain that binds to plasma membrane and cytoskeletal elements. This PTP was found to interact with, and dephosphorylate, Fas receptor and IkappaBalpha through the PDZ domains. This suggests it has a role in Fas mediated programmed cell death. This PTP was also shown to interact with GTPase-activating protein, and thus may function as a regulator of Rho signaling pathways. Four alternatively spliced transcript variants, which encode distinct proteins, have been reported. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.007832199).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PTPN13NM_080683.3 linkuse as main transcriptc.744T>G p.Asp248Glu missense_variant 7/48 ENST00000411767.7 NP_542414.1 Q12923-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PTPN13ENST00000411767.7 linkuse as main transcriptc.744T>G p.Asp248Glu missense_variant 7/481 NM_080683.3 ENSP00000407249.2 Q12923-1

Frequencies

GnomAD3 genomes
AF:
0.000861
AC:
131
AN:
152202
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.0110
Gnomad AMR
AF:
0.000916
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00129
Gnomad OTH
AF:
0.00143
GnomAD3 exomes
AF:
0.000647
AC:
160
AN:
247374
Hom.:
0
AF XY:
0.000701
AC XY:
94
AN XY:
134164
show subpopulations
Gnomad AFR exome
AF:
0.000261
Gnomad AMR exome
AF:
0.000642
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000559
Gnomad SAS exome
AF:
0.0000987
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.00109
Gnomad OTH exome
AF:
0.000831
GnomAD4 exome
AF:
0.000913
AC:
1334
AN:
1460400
Hom.:
1
Cov.:
31
AF XY:
0.000885
AC XY:
643
AN XY:
726448
show subpopulations
Gnomad4 AFR exome
AF:
0.0000598
Gnomad4 AMR exome
AF:
0.000784
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.000128
Gnomad4 FIN exome
AF:
0.0000562
Gnomad4 NFE exome
AF:
0.00110
Gnomad4 OTH exome
AF:
0.000995
GnomAD4 genome
AF:
0.000860
AC:
131
AN:
152320
Hom.:
0
Cov.:
32
AF XY:
0.000765
AC XY:
57
AN XY:
74494
show subpopulations
Gnomad4 AFR
AF:
0.000385
Gnomad4 AMR
AF:
0.000915
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00129
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.00118
Hom.:
0
Bravo
AF:
0.000839
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000550
AC:
2
ESP6500EA
AF:
0.000613
AC:
5
ExAC
AF:
0.000580
AC:
70

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 26, 2021The c.744T>G (p.D248E) alteration is located in exon 7 (coding exon 6) of the PTPN13 gene. This alteration results from a T to G substitution at nucleotide position 744, causing the aspartic acid (D) at amino acid position 248 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
16
DANN
Uncertain
0.99
DEOGEN2
Benign
0.11
.;.;.;T;.
Eigen
Benign
-0.11
Eigen_PC
Benign
-0.15
FATHMM_MKL
Benign
0.59
D
LIST_S2
Benign
0.74
T;T;T;T;.
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.0078
T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.8
L;L;L;L;L
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-0.91
N;N;N;N;N
REVEL
Benign
0.092
Sift
Uncertain
0.015
D;D;D;D;D
Sift4G
Benign
0.47
T;T;T;T;T
Polyphen
0.96
P;D;P;D;D
Vest4
0.10
MutPred
0.20
Gain of glycosylation at T249 (P = 0.0082);Gain of glycosylation at T249 (P = 0.0082);Gain of glycosylation at T249 (P = 0.0082);Gain of glycosylation at T249 (P = 0.0082);Gain of glycosylation at T249 (P = 0.0082);
MVP
0.45
MPC
0.21
ClinPred
0.035
T
GERP RS
0.85
Varity_R
0.082
gMVP
0.17

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs202182886; hg19: chr4-87622503; COSMIC: COSV104414286; API